Table II.

Characteristics of 3 non-responders to 8-week LDV/SOF regimen

Patient	Regimen	Genotype	History of previous therapy	Fibrosis	Baseline HCV RNA × 106 IU/ml	EOT	Comment
Female 1	LDV/SOF	1B	DCV + IFN + RBV	1	1.34	TND	Relapser after treatment with DCV + IFN + RBV
Female 2	LDV/SOF	1B	Treatment-naïve	1	0.08	TD	None
Female 3	LDV/SOF	1B	Treatment-naïve	2	2.03	TND	None

LDV – ledipasvir, SOF – sofosbuvir, HCV RNA – hepatitis C virus ribonucleic acid, EOT – end of treatment, DCV – daclatasvir, IFN – interferon, RBV – ribavirin, TND – target not detected, TD – target detected.